Kavya Patel, MD

Kavya Patel, MD, is now accepting new patients. She has been practicing internal medicine since 2010 and infectious diseases since 2018. 

In her department, she has been involved in the education of other providers and our community about COVID-19 disease activity, therapeutics, developing infection prevention strategies for the hospital as well as increasing awareness about the COVID-19 vaccine.

In her current research study, Dr. Patel and her team seek to characterize the microbiome signature that can predict treatment success with immune checkpoint inhibitors (ICI). Cancer immunotherapy has surged to the forefront of cancer therapeutics over the last several years. These agents have provided patients with hope for conditions that otherwise had little to no therapeutic options. She believes this success has been tainted by the fact that these therapies have only been successful in a subset of patients. Her study aims to assess microbiome profiles using next generation sequencing to outline molecular pathways underlying ICI resistance.

During her residency in internal medicine at Saint Peter’s University, she noticed there are many emerging infectious diseases which we have yet to fully understand treatments for, as well as how to control dissemination in our community. She believes that infectious diseases have continued to take the lives of many, despite research in the field.

It gives Dr. Patel immense pleasure when she is able to assist the medical team in developing an appropriate care plan utilizing her knowledge and enhanced training. Through this, she has developed a special interest toward transplant infectious diseases given the intriguing nature of infections in our immunocompromised populations.

Outside of the health system, Dr. Patel is a “fitness freak,” who describes the gym as being her second home. She enjoys being outdoors, hiking, swimming and traveling, as well as spending quality time with her family.